Topical nonsteroidal anti-inflammatory drugs for pain resulting from intravitreal injections: a meta-analysis

MM Popovic, RH Muni, P Nichani, PJ Kertes - Ophthalmology Retina, 2020 - Elsevier
Topic The role of topical nonsteroidal anti-inflammatory drugs (NSAIDs) for the reduction of
ocular pain after intravitreal injections (IVIs) has been explored. To provide clarity on the …

Randomized safety and feasibility trial of ultra-rapid cooling anesthesia for intravitreal injections

CG Besirli, SJ Smith, DN Zacks, TW Gardner… - Ophthalmology …, 2020 - Elsevier
Purpose To test the safety and preliminary efficacy of rapid, nonpharmacologic anesthesia
via cooling for intravitreal injections. Design Single-center, randomized phase 1 dose …

Pain control after intravitreal injection using topical nepafenac 0.3% or pressure patching: a randomized, placebo-controlled trial

RI Kaplan, OJ Drinkwater, RH Lee, RB Chod… - Ophthalmology …, 2019 - Elsevier
Purpose Pain after an intravitreal injection (IVI) can last up to 7 days and negatively impacts
the patient's experience, potentially reducing treatment compliance. We prospectively …

Evaluation effectiveness of 0.1% nepafenac on injection-related pain in patients undergoing intravitreal Ozurdex injection

T Ogurel, R Ogurel, F Ozkal, Y Ölmez… - Therapeutic …, 2019 - journals.sagepub.com
Purpose: To evaluate the analgesic effect of topical 0.1% nepafenac solution during
intravitreal Ozurdex injection. Methods: This prospective, randomized, double-blind placebo …

Comparison of the Effects of Eight Different Topical Non-Steroidal Anti-Inflammatory Drugs on Reducing Intravitreal Injection-induced Pain.

AK Sakallioğlu, S Kaya, R Garip, H Güçlü - RETINA, 2022 - journals.lww.com
Purpose: To compare topical nonsteroidal anti-inflammatory drug (NSAID) efficacy on
intravitreal injection (IVI)-induced pain reduction, and determine the most efficient topical …

[HTML][HTML] Controversies in Care: Chlorhexidine as an Alternative to Povidone-iodine for Antisepsis Before Intravitreal Injection

M Colucciello, J Fan, HW Flynn Jr, S Garg… - retinalphysician.com
Intravitreal injections are the most common procedures performed in the United States
today: it is estimated that 7 million intravitreal injections are performed yearly, 1 compared to …

Nepafenac Drop Reduces Ocular Pain Associated with Dexamethasone Intravitreal Implant

M Ozcimen, HI Yener - 2022 - researchsquare.com
Purpose: To assess the effects of nepafenac ophthalmic suspension 0.1% for the control of
pain experienced after dexamethasone intravitreal implant (Ozurdex) injections. Methods …